Print this page
Choices About Genetic Testing And Learning Your Risk with Smart Technology (CATALYST)
The study's objectives are to: 1) finalize the development and optimize usability of the CATALYST digital intervention (i.e., RA also known as relational assistant (RA)); 2) evaluate the feasibility and acceptability of a streamlined cancer genomic care delivery in cancer survivors. Participants will be randomized to one of two study arms which are the RA intervention vs. enhanced usual care (EUC); and 3) Conduct a process evaluation to measure barriers/facilitators to GC, GT and use of the CATALYST intervention and engagement with the RA.
Protocol Number:
132307
Phase:
N/A
Applicable Disease Sites:
Pancreas
Other Female Genital
Prostate
Colon
Ovary
Breast
Other Female Genital
Prostate
Colon
Ovary
Breast
Principal Investigator:
Anita Kinney PhD,RN
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
For further information about clinical trials, please contact us at 732-235-7356.